The results indicate the administration improves the microenvironment and rescues haematopoietic defects in Bmi1-null mice, thereby revealing a potential value of PTH1-34, an anabolic drug for osteoporosis, for repairing haematopoietic defects. This evidence concerns the gene PTH and osteoporosis.